Alexandria Real Estate Equities
ARE
$117.30
Share price
-1.96%
Change (1 day)
-5.44%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Operating Margin for Alexandria Real Estate Equities (ARE)
Operating Margin as of April 2024 (TTM): 29.44%
According to Alexandria Real Estate Equities 's latest financial reports and stock price the company's current Operating Margin is 29.44%. At the end of 2022 the company had an Operating Margin of 25.91%.
Operating Margin history for Alexandria Real Estate Equities from 2012 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 25.91% | -16.29% |
| 2021 | 30.95% | -29.45% |
| 2020 | 43.87% | 66.25% |
| 2019 | 26.39% | -13.04% |
| 2018 | 30.34% | 75.7% |
| 2017 | 17.27% | -411.39% |
| 2016 | -5.55% | -131.1% |
| 2015 | 17.83% | 22.82% |
| 2014 | 14.52% | -34.23% |
| 2013 | 22.08% | 40.79% |
| 2012 | 15.68% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | 17.56% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -16.24% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 17.49% | 🇺🇸 USA |
 Gilead Sciences GILD | 26.84% | -8.83% | 🇺🇸 USA |
 Illumina ILMN | -94.58% | -421.26% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -34.65% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -108.63% | -468.99% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.